skip to Main Content
blank

Nephrocare Health IPO listing LIVE: Share price extends losses after firm debut, down 7% from day’s high | Stock Market News

Nephrocare Health ipo listing Live: Nephrocare Health share price extends losses after a firm listing. It fell 7% to its day’s low of 463.50 from its day’s high of 498.70 on BSE. It is now just 0.7% up from its issue price of 460.

Nephrocare Health share price made a strong debut in the Indian stock market today, December 17. Nephrocare share price was listed on Wednesday at 490 apiece on NSE, a premium of 6.5% from its issue price of 460. Meanwhile, on BSE, it listed at 491.70, up 6.89% from issue price.

blank

Open A/C With Motilal Oswal

Upto 4X Margin Funding in Equity

Free Account Opening

The Nephrocare Health IPO underperformed Street expectations, as seen from the grey market premium (GMP). The GMP for the IPO stood at 37 per share, which indicated a likely listing price of around 497 — translating to a premium of 8% over the upper end of the issue price band.

The initial public offering (IPO) of Nephrocare Health Services attracted strong demand from all three investor categories during its primary issue.

On the final day of bidding, the Nephrocare Health IPO was subscribed 13.96 times, with investors bidding for 18,68,93,536 shares against the 1,33,87,854 shares available, according to BSE data. Qualified Institutional Buyers (QIBs) emerged as the most aggressive participants with a subscription of 27.47 times, followed by the Non-Institutional Investors (NII) segment at 24.27 times, while the retail portion was oversubscribed 2.31 times by the end of Day 3.

Nephrocare Health is an Indian dialysis and renal care provider that has expanded its presence across Tier-2 and Tier-3 cities through strategic partnerships and an asset-light operating model. The company runs a network of clinics across India and a few international markets.

Nephrocare Health IPO Details

Nephrocare Health’s IPO was a book-built public issue featuring a combination of a fresh issue and an offer for sale (OFS), with the company aiming to raise nearly 871 crore from the market. The price band was fixed at 438–460 per share, and the lot size was 32 shares per lot, translating into a minimum retail investment of 14,720 at the upper end of the band.

The issue was open for subscription between December 10–12, with allotment finalised on December 15.

Related Articles

The opinions and investment advice provided by experts on ipogmp.org are solely their own and do not reflect the views of the website or its management. Ipogmp.org recommends that users consult with certified professionals before making any investment decisions. *Please note that advisory services mentioned on Ipogmp.org are not currently operational and are proposed services awaiting SEBI registration.

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top